Guideline implementation in a multicenter study with an estimated 44% relative cardiovascular event risk reduction

Clinical Cardiology

Volumn 26, Issue 5, 2003, Pages 243-249

  Onat, Altan ^a,e   Soydan, Inan ^c   Tokgözoǧlu, Lale ^d   Sansoy, Vedat ^f   Koylan, Nevres ^b   Domaniç, Nergiz ^a   Ural, Dilek ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

^b IU Istanbul Medical Faculty   (Turkey)

^c EGE UNIVERSITY   (Turkey)

^d HACETTEPE UNIVERSITY   (Turkey)

^e Turkish Society of Cardiology   (Turkey)

^f NONE

Author keywords

Coronary risk reduction; Guideline implementation; Preventive cardiology

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CLINICAL PRACTICE; CLINICAL TRIAL; CORONARY RISK; FEMALE; HIGH RISK POPULATION; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MALE; MULTICENTER STUDY; PRACTICE GUIDELINE; PRIMARY PREVENTION; RISK ASSESSMENT;

EID: 0038556753     PISSN: 01609289     EISSN: None     Source Type: Journal    
DOI: 10.1002/clc.4960260510     Document Type: Article

References (19)

1. Pyörala K, De Backer G, Graham I, Poole-Wilson P, Wood D: Prevention of coronary heart disease in clinical practice. Recommendations of the Task Force of the European Society of Cardiology, European Atherosclorosis Society, and European Society of Hypertension. Eur Heart J 1994;15:1300-1331
2. Türk Kardiyoloji Derneǧi: Koroner Kalp Hastaliǧindan Korunma ve Tedaviye Ilişkin Ulusal Kilavuz. Istanbul: Türk Kardiyol Dern, 1995
3. Murray CJL, Lopez AD: Alternative projections of mortality and disability by cause 1990-2020: Global burden of disease study. Lancet 1997;349:1498-1504
4. Pearson TA, Smith SC Jr, Poole-Wilson P: Cardiovascular Specialty Societies and the emerging global burden of cardiovascular disease: A call to action. Circulation 1998;97:602-604
5. European Forum on the Prevention of Coronary Heart Disease in Clinical Practice (19-21 February 1999). Newsletter by European Society of Cardiology, 1999 (May); vol. 8 (no. 2)
6. Capewell S, Pell JP, Morrison C, McMurray J: Increasing the impact of cardiological treatments: How best to reduce deaths. Eur Heart J 1999;20:1386-1392
7. Onat A, Sansoy V, Ince E, Dönmez K, Keleş I, Ökçün B, Kahraman G, Dursunoǧlu D: Türk erişkinlerinde kanda kolesterolde istikrar, trighseridde yükselme. Türk Kardiyol Dern Aq 1996;24:392-398
8. Onat A: Risk factors and cardiovascular disease in Turkey. Atherosclerosis 2001;156:1-10
9. Mahley RW, Palaoǧlu KE, Atak Z, Dawson-Pepin J, Langlois A-M, Cheung V, Onat H, Fulks P, Mahley LL, Vakar F, Özbayrakçi S, Gökdemir O, Winkler W: Turkish Heart Study: Lipids, lipoproteins and apolipoproteins. J Lipid Res 1995;36:839-859
10. Onat A, Dursunoǧlu D, Sansoy V: Relatively high coronary death and event rates in Turkish women: Relation to three major risk factors in five-year follow-up of cohort. Int J Cardiol 1997:61:69-77
11. Anderson KM, Wilson PWF, Odell PM, Kannel WB: An updated coronary risk profile: A statement for health professionals. Circulation 1991;83:356-362
12. Dawson-Saunders B, Trapp RG: Basic and Clinical Biostatistics. Englewood Cliffs, N.J.: Prentice-Hall International Inc., Appleton & Lange
13. Wood D, De Backer G, Faergeman O, Graham I, Mancia G, Pyörala K: Prevention of coronary heart disease in clinical practice. Recommendations of the Second Joint Task Force of the European and other societies on coronary prevention. Eur Heart J 1998;19:1434-1503
14. Menotti A. Puddu PE, Lanti M: Comparison of the Framingham risk function-based coronary chart with risk function from an Italian population study. Eur Heart J 2000;21:365-370
15. Sacks FM, Pfeffer MA, Moyé LA, Rouleau JL, Rutherford JD, Cole TG, Brown L, Warnicka JW, Arnold JMO, Wun C-C, Davis BR, Braunwald E: The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. N Engl J Med 1996;335:1001-1009
16. EUROASPIRE Study Group:; EUROASPIRE: A European Society of Cardiology survey of secondary prevention of coronary heart disease: Principal results. Eur Heart J 1997;18:1569-1582
17. van Berkel TFM, Boersma H, De Baquer D, Deckers JW, Wood D, on behalf of the EUROASPIRE Study Group: Registration and management of smoking behaviour in patients with coronary heart disease. The EUROASPIRE Survey. Eur Heart J 1999;20:1630-1637
18. Shepherd J: A call to action. Eur Heart J 1998;19(suppl M):M2-M7
19. Assmann G, Cullen P, Schulte H: Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the Prospective Cardiovascular Münster (PROCAM) study. Circulation 2002;105:310-315